We implemented cytolytic findings to clinical parameters, such as loss of 10q, again a 5q which is a better prognosis factor, also loss of sexual chromosome for T3 pathologic patients.
The main finding of this classification, the accuracy of the high-risk group is 83% to predict high-risk recurrence. It’s better than the other classification whose previews I assess with an IUC for 0.72 versus 0.65, so it’s significantly better.